REVLIMID for Chronic lymphocytic leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 121 adverse event reports in the FDA FAERS database where REVLIMID was used for Chronic lymphocytic leukaemia.
Most Reported Side Effects for REVLIMID
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pneumonia | 652 | 7.3% | 85 | 589 |
| Plasma cell myeloma | 632 | 7.1% | 241 | 184 |
| Death | 565 | 6.4% | 564 | 51 |
| Diarrhoea | 508 | 5.7% | 20 | 207 |
| Thrombosis | 484 | 5.5% | 4 | 165 |
| Fatigue | 448 | 5.1% | 17 | 149 |
| Platelet count decreased | 362 | 4.1% | 9 | 112 |
| Full blood count decreased | 352 | 4.0% | 6 | 172 |
| Deep vein thrombosis | 332 | 3.7% | 6 | 154 |
| Pancytopenia | 319 | 3.6% | 20 | 91 |
| Rash | 310 | 3.5% | 11 | 88 |
| Anaemia | 286 | 3.2% | 28 | 145 |
| White blood cell count decreased | 284 | 3.2% | 4 | 102 |
| Neutropenia | 253 | 2.9% | 33 | 93 |
| Asthenia | 239 | 2.7% | 17 | 136 |
Other Indications for REVLIMID
Plasma cell myeloma (7,122)
Myelodysplastic syndrome (835)
Lymphoma (121)
Product used for unknown indication (90)
Mantle cell lymphoma (76)
5q minus syndrome (72)
Acute myeloid leukaemia (56)
Amyloidosis (56)
Myelofibrosis (52)
B-cell lymphoma (41)
Other Drugs Used for Chronic lymphocytic leukaemia
IBRUTINIB (37,003)
VENETOCLAX (14,194)
RITUXIMAB (7,231)
OBINUTUZUMAB (4,557)
ACALABRUTINIB (4,515)
IDELALISIB (3,537)
CYCLOPHOSPHAMIDE (3,085)
FLUDARABINE (2,777)
BENDAMUSTINE (2,561)
CHLORAMBUCIL (1,242)